An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

The shingles vaccine not only offers protection against the painful viral infection, but a new study suggests that the two-dose shot also may slow the progression of dementia.

Vaccine advisers to the US Centers for Disease Control and Prevention are meeting today, and they could vote on possible changes to the childhood vaccination schedule. Follow here for live updates ...

Influenza prevention with the cell-based quadrivalent vaccine (QIVc) was superior to the egg-based vaccine (QIVe) during the US 2022–2023 flu season.

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

A Pew Research Center survey conducted last month and published this past week found 63% of Americans have high confidence in ...

An unusual public health policy in Wales may have produced the strongest evidence yet that a vaccine can reduce the risk of ...

A study by Epi-Phare published on Thursday addresses misinformation surrounding vaccines that have been widely distributed ...

Vaccine advisers to the US Centers for Disease Control and Prevention are meeting today, and they could vote on possible changes to the childhood vaccination schedule. Follow here for live updates ...

More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA ...

Americans are more likely to accept guidance on vaccines from the American Medical Association (AMA) than from the Centers ...